Volume 95 Issue 7 | pp. 28-33
Issue Date: February 13, 2017

Cover Story

CRISPR’s breakthrough problem

If the CRISPR gene editing system is to live up to its disease-curing potential, researchers must devise a plan to deliver it into the body
Department: Science & Technology, Business
Keywords: biotechnology, CRISPR, drug delivery, CRISPR/Cas9, gene editing, lipid nanoparticles, AAV, Intellia

In fewer than five years, an important new gene-editing tool called CRISPR has radically changed the face and pace of biological research. The ability to quickly and cleanly remove and replace stretches of DNA has already inspired thousands of publications featuring the technique and led to the creation of a slew of biotech businesses hoping to capitalize on CRISPR.

CRISPR’s power to . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society